Medical innovation demands many contributors across a range of touchpoints. We in the biopharmaceutical industry often define our role as discovering new medicines and vaccines, conducting clinical trials to demonstrate their safety and efficacy profiles, and working to get them to physicians and their patients who may benefit from them. That is obviously an essential effort in addressing unmet medical need. But it is increasingly clear that people do not fully reap the intended benefits of medical inventions unless they first understand their diagnosis, why their doctors recommend certain treatments, and how to take their medicines correctly.

Many of us across health care recognize this intersection where medicine meets patient understanding as health literacy. Textbooks define *health literacy* as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. People's level of health literacy hinges on understanding three elements: the medical condition or disease, the reasons a specific treatment has been selected for them, and the appropriate behaviors and use of treatments that can improve their condition while minimizing the risk of side effects.

So essential are these skills among the population at large that former Surgeon General Richard Carmona ([@CIT0002]) called the poor state of health literacy in America a crisis---a source of patient disempowerment and perpetuation of preventable disease.

Nearly a decade later, stories that illustrate the problem of low health literacy---and the breadth of our opportunity---still are too common. Patients abandon cholesterol regimens when they reach their target blood cholesterol level. They stop taking necessary, lifelong thyroid medication when prescribed a short-term antibiotic because they mistakenly fear interference between the two medicines. They check "no" to all questions on a medical history to hide poor reading skills. Low health literacy is a serious challenge to improving health outcomes globally, sometimes leading to increased hospitalization rates, less frequent screening for disease, and disproportionately high rates of disease and mortality. Research shows that low health literacy is highly prevalent among patients with some of the most common and costly diseases in society---diabetes, hypertension, and asthma (U.S. Department of Health and Human Services, n.d.)---as well as a strong correlation between patients' poor knowledge of their conditions and higher rates of nonadherence and medication errors.

Communication must be part of the care and the cure. If patients do not have the tools they need to understand their disease, engage in shared decision making, and manage their health, including following appropriate health guidance, then the intended benefits of medical care and medicines can be compromised---or wasted altogether. It is up to all of us in the health community to make improving health literacy part of our calling.

The *Ten Attributes of Health Literate Health Care Organizations* (Brach et al., [@CIT0001]) cites "a growing appreciation that health literacy does not depend on the skills of individuals alone." In other words, everyone involved in health care is included in the circle of care. The Ten Attributes guides organizations toward basic steps that can help improve health literacy and, ultimately, health outcomes. From leadership behavior to planning and evaluation measures, shifting our mindsets within our organizations to recognize the importance of health literacy can make a difference for all patients.

Research-driven companies like Merck are in a unique position to help given their role in moving discoveries from the lab into the clinic. For what good is medical invention if it does not achieve its mission---to heal? This is a journey that involves multiple touchpoints with patients and their families and all of the other stakeholders who influence the patient experience---physicians and other providers, advocates, payers, and policymakers. Each touchpoint is an opportunity for education and greater understanding.

Our company's journey has evolved significantly during the past 5 years. Initially we pursued three goals: advancing understanding of health literacy as a discipline, including research and its communication; developing and applying health literacy principles in disease education and related materials; and developing tools and services for patients, health care providers, and the broader environment, including online resources and speaker programs. We continue this work and share best practices across regions where we are working---the United States and Europe.

More recently, we shifted attention toward addressing the need for health literacy in clinical trials. This work entails contributing to new thinking around processes for developing patient labeling for new drug candidates, communicating clinical trial results to participants, improving participation of underrepresented populations in clinical trials, and listening to input from patients and family members early in the design of our clinical trials. It also involves funding research to improve adherence and health outcomes by applying health literacy in novel, scalable, evidence-based methods as well as starting to apply health literacy principles to sample packaging. Other efforts are under way to include respondents with low health literacy in marketing research---a segment historically not represented---and championing health literacy in health care policy in Europe.[^1^](#FN0001){ref-type="fn"} [^2]

At a time when patients and family members are increasingly engaged in their own care, clear communication with patients at every stage of the process has never been more crucial. Health literacy principles enable all in the health care field to help patients better understand and weigh their choices---through the risk--benefit of medicines and also "risk--risk"---the possible risk of letting the disease take its natural course versus the possible risks of treatment.

Along the patient journey, from researching symptoms, to seeking diagnosis, to managing self-care for a chronic illness, there are countless opportunities to help explain and support patients' and caregivers' participation in their well-being.

The discussion of health literacy has evolved to recognize individual skills and abilities and the pressing realities of a daunting health care system. This complexity has been highlighted with the implementation of the Affordable Care Act, as people who may not have previously had health insurance sometimes struggle to navigate the complex health care system while facing out-of-pocket expenses. Among diverse populations, some have faced challenges in enrollment because of language and cultural barriers. Fostering access to quality care, including medicines, is a part of our company's mission. Low health literacy contributes to disparities in health care and is a significant, but moveable, barrier to access.

We hope this special issue on health literacy inspires you in your work. No matter what your role in the health care system---physician, nurse, office staff, pharmacist, administrator, industry researcher or clinician, health insurer or policymaker---if you are shaping health communications, directly or indirectly, we challenge you to define how you personally can improve health literacy. Take a first step---identify a small pilot that is likely to be successful. As we have discovered, understanding what is possible will evolve and expand as you actively engage, and so will your impact.

[^1]: Michael Rosenblatt is Executive Vice President and Chief Medical Officer, and Laurie Myers is Global Health Literacy Director, at Merck & Co., Inc.

[^2]: For more information about Merck's health literacy efforts, please see our 2014 corporate responsibility report at <https://www.merckresponsibility.com/access-to-health/health-literacy-healthcare-disparities/>.
